Elequin Capital’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $740 | Buy |
+50
| New | +$740 | ﹤0.01% | 291 |
|
|
2024
Q4 | – | Sell |
-462
| Closed | -$6.46K | – | 613 |
|
|
2024
Q3 | $6.46K | Buy |
+462
| New | +$6.46K | ﹤0.01% | 270 |
|
|
2024
Q2 | – | Sell |
-1,430
| Closed | -$11K | – | 354 |
|
|
2024
Q1 | $11K | Buy |
1,430
+1,410
| +7,050% | +$10.9K | ﹤0.01% | 90 |
|
|
2023
Q4 | $180 | Sell |
20
-6
| -23% | -$54 | ﹤0.01% | 337 |
|
|
2023
Q3 | $232 | Sell |
26
-504
| -95% | -$4.5K | ﹤0.01% | 362 |
|
|
2023
Q2 | $8.14K | Buy |
+530
| New | +$8.14K | ﹤0.01% | 326 |
|
|
2023
Q1 | – | Sell |
-7,088
| Closed | -$149K | – | 523 |
|
|
2022
Q4 | $149K | Buy |
+7,088
| New | +$149K | 0.04% | 215 |
|
|
2022
Q3 | – | Sell |
-388
| Closed | -$9K | – | 676 |
|
|
2022
Q2 | $9K | Buy |
388
+354
| +1,041% | +$8.21K | ﹤0.01% | 252 |
|
|
2022
Q1 | $1K | Buy |
+34
| New | +$1K | ﹤0.01% | 303 |
|